Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-28 Sale | 2024-08-30 4:16 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I L.P. Versant Voyageurs I Parallel L.P. Versant Vantage I L.P. 10% Owner | 221,600 | $6.3202 | $1,400,556 | 6,206,964 (Indirect Direct) | View |
| 2022-01-03 Sale | 2022-01-05 5:16 pm | CHINOOK THERAPEUTICS INC. | KDNY | Versant Venture Capital VII L.P. Versant Voyageurs I L.P. Versant Voyageurs I Parallel L.P. 10% Owner | 1,000,000 | $16 | $16,000,200 | 4,175,172 (Indirect Direct) | View |
| 2021-08-27 Sale | 2021-08-31 7:06 pm | CHINOOK THERAPEUTICS INC. | KDNY | Versant Venture Capital VII L.P. Versant Voyageurs I L.P. Versant Voyageurs I Parallel L.P. 10% Owner | 850,000 | $14 | $11,900,000 | 4,867,172 (Indirect Direct) | View |
| 2020-11-30 Sale | 2020-12-01 7:13 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 10,393 | $33.15 | $344,513 | 6,062,813 (Indirect Direct) | View |
| 2020-11-19 Sale | 2020-11-23 4:41 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 130,017 | $33.01 | $4,291,861 | 7,646,829 (Indirect Direct) | View |
| 2020-11-17 Sale | 2020-11-19 9:19 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 4,730 | $33.05 | $156,349 | 7,776,846 (Indirect Direct) | View |
| 2020-11-13 Sale | 2020-11-17 7:33 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 4,700 | $33.74 | $158,587 | 7,781,576 (Indirect Direct) | View |
| 2020-11-12 Sale | 2020-11-13 7:47 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 15,598 | $34.15 | $532,642 | 6,937,033 (Indirect Direct) | View |
| 2020-11-10 Sale | 2020-11-12 5:41 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 39,583 | $34.11 | $1,350,354 | 8,751,874 (Indirect Direct) | View |
| 2020-11-06 Sale | 2020-11-10 7:24 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 9,400 | $33.08 | $310,949 | 8,791,457 (Indirect Direct) | View |
| 2020-11-04 Sale | 2020-11-06 4:44 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 11,348 | $33.14 | $376,127 | 8,800,857 (Indirect Direct) | View |
| 2020-10-26 Sale | 2020-10-28 5:58 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 8,903 | $33.28 | $296,293 | 8,812,205 (Indirect Direct) | View |
| 2020-10-15 Sale | 2020-10-20 8:09 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 15,746 | $33.44 | $526,529 | 8,821,108 (Indirect Direct) | View |
| 2020-10-13 Sale | 2020-10-15 7:22 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 17,240 | $33.3 | $574,015 | 8,836,854 (Indirect Direct) | View |
| 2020-10-08 Sale | 2020-10-13 7:41 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 22,625 | $33.5 | $757,924 | 8,854,094 (Indirect Direct) | View |
| 2020-10-06 Sale | 2020-10-08 7:14 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 45,926 | $33.44 | $1,535,732 | 6,056,892 (Indirect Direct) | View |
| 2020-08-10 Sale | 2020-08-12 7:57 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 13,792 | $33.06 | $455,989 | 10,541,469 (Indirect Direct) | View |
| 2020-02-03 Purchase | 2020-02-05 6:02 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 894,736 | $19 | $16,999,984 | 8,016,017 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-04-04 Other | 2022-04-06 4:38 pm | N/A N/A | CHINOOK THERAPEUTICS INC. | KDNY | Versant Venture Capital VII L.P. Versant Voyageurs I L.P. Versant Voyageurs I Parallel L.P. 10% Owner | 735,873 | $0 | 6,090,209 (Direct) | View |
| 2020-12-14 Other | 2020-12-16 7:04 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 21,401 | $0 | 5,628,442 (Indirect) | View |
| 2020-11-27 Other | 2020-12-01 7:13 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 440,782 | $0 | 6,062,813 (Direct) | View |
| 2020-11-23 Other | 2020-11-25 4:49 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 788,828 | $0 | 5,151,052 (Direct) | View |
| 2020-11-11 Other | 2020-11-13 7:47 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 984,298 | $0 | 6,937,033 (Direct) | View |
| 2020-10-07 Other | 2020-10-08 7:14 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 299,051 | $0 | 6,056,892 (Indirect) | View |
Ownership | 2020-10-07 8:25 pm | N/A N/A | ADURO BIOTECH INC. | KDNY | Versant Venture Capital VII L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. 10% Owner | 0 | $0 | 7,888,369 (Indirect) | View |
| 2020-09-17 Other | 2020-09-21 7:28 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 754,743 | $0 | 6,569,238 (Direct) | View |
| 2020-08-18 Other | 2020-08-20 6:13 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 311,176 | $0 | 10,263,821 (Direct) | View |
| 2020-08-12 Other | 2020-08-14 5:55 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 311,176 | $0 | 10,563,821 (Direct) | View |
| 2020-07-27 Other | 2020-07-29 9:56 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 339,843 | $0 | 7,151,621 (Indirect) | View |
| 2020-02-03 Conversion | 2020-02-05 6:02 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 38,785,347 | $0 | 8,016,017 (Direct) | View |
Ownership | 2020-01-29 8:12 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 0 | $0 | 9,989,742 (Direct) | View |